Bluejay diagnostics announces clinical update and reports second quarter 2023 financial results

Acton, mass., aug. 16, 2023 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay” or the “company”), a medical technology company developing rapid diagnostics on its symphony platform to improve patient outcomes in critical care settings, announced financial results for the six months ended june 30, 2023.
BJDX Ratings Summary
BJDX Quant Ranking